Johnson & Johnson (JNJ.N) is negotiating a deal to acquire Swiss biotechnology company Actelion Ltd (ATLN.S) that would separate its commercialized portfolio from its research and development assets, people familiar...
Actelion re-enters talks with J&J, sidelining Sanofi
Swiss biotech company Actelion (ATLN.S) has turned back to prospective bidder Johnson & Johnson (JNJ.N) for exclusive talks about a “strategic transaction”, in an about-turn that appears to sideline...
OMCs shut biodiesel joint ventures due to lack of commercial viability
Mumbai: Once touted as the fuel of the future, biodiesel, extracted from jatropha seeds, has lost its sheen for oil marketing companies. Due to lack of availability and commercial viability, the three oil marketing...
Carlyle Group emerges front-runner for Bharat Biotech stake
The world’s second-largest private equity fund, the Carlyle Group, which ranks India as the most attractive global investment destination has emerged as the front-runner to buy out the stakes of three PE investors...
Biogen draws takeover interest from Merck, Allergan: WSJ
Biotechnology company Biogen Inc (BIIB.O) has drawn takeover interest from drug companies including Merck & Co Inc (MRK.N) and Allergan Plc (AGN.N), The Wall Street Journal reported on Tuesday, citing people...
TPG Growth picks up minority stake in Bengaluru-based Rhea Healthcare
MUMBAI: Global private equity fund TPG Growth has picked up a significant minority stake in Bengaluru-based Rhea Healthcare, a company that operates mother and child care centres in the country for $33M investment...
Monsanto Due Diligence Looms as Next Step in Bayer Deal Push
First came the initial bid, then the rejection. Now, the next step in Bayer AG’s quest to buy Monsanto Co. and create the world’s largest agricultural company is likely to hinge on whether the U.S. seed giant will agree...
Origin withdraws offer to buy Affymetrix
Origin Technologies Corp, owned by Affymetrix Inc’s (AFFX.O) former employees, withdrew its offer to buy the gene-sequencing products maker, hours after Affymetrix said on Monday that Origin’s raised bid was...
Startup Stemcentrx exploring strategic options, including sale
Stemcentrx Inc, a San Fransisco-based biotechnology startup, is pursuing strategic alternatives including a sale, the Wall Street Journal reported. The company, backed by PayPal Holdings Inc (PYPL.O) co-founder Peter...
CCI suspects Monsanto JV abused dominant position
Competition Commission of India (CCI) has ordered an investigation into a Monsanto joint venture, saying it suspected the company had abused its dominant position as a supplier of genetically modified (GM) cotton seeds...
Global private equity giants eye stake in Bharat Biotech.
Hyderabad based biotechnology firm Bharat Biotech which recently claimed that it was probably the first company in the world to file global patents for Zika vaccines, has attracted the attention of marquee private...
Bharat Biotech likely to be valued at $600 million as top PE firms queue up to buy stake.
Top global private equity firms Carlyle Group and TPG Capital Management are among those in talks to buy out the stakes of three PE investors in Bharat Biotech, the Indian company that has unveiled Zika vaccine...
